MoneyWorks4Me

Nectar Lifesciences - Quaterly Results

14 Feb 2023 Evaluate
The sales is pegged at Rs. 3441.25 millions for the December 2022 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 4430.01 millions during the year-ago period.The Net Loss for the quarter ended December 2022 is Rs. -92.89 millions as compared to Net Profit of Rs. 97.32 millions of corresponding quarter ended December 2021Operating profit for the quarter ended December 2022 decreased to 146.85 millions as compared to 471.19 millions of corresponding quarter ended December 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 3441.25 4430.01 -22.32 11357.95 11920.23 -4.72 16682.56 15428.96 8.12
Other Income 132.40 5.30 2398.11 243.14 107.73 125.69 112.93 27.22 314.88
PBIDT 146.85 471.19 -68.83 602.04 1204.61 -50.02 1701.31 1129.49 50.63
Interest 174.64 176.24 -0.91 598.18 613.78 -2.54 788.10 1120.32 -29.65
PBDT -27.79 294.95 -109.42 3.86 590.83 -99.35 913.21 -243.98 -474.30
Depreciation 147.84 142.78 3.54 442.70 427.10 3.65 569.68 602.53 -5.45
PBT -175.63 152.17 -215.42 -438.84 163.73 -368.03 343.53 -846.51 -140.58
TAX -82.74 54.85 -250.85 -160.63 27.10 -692.73 90.34 -115.04 -178.53
Deferred Tax -82.74 54.85 -250.85 -160.63 27.10 -692.73 90.34 -200.90 -144.97
PAT -92.89 97.32 -195.45 -278.21 136.63 -303.62 253.19 -731.47 -134.61
Equity 224.26 224.26 0.00 224.26 224.26 0.00 224.26 224.26 0.00
PBIDTM(%) 3.80 9.18 -58.67 5.30 10.11 -47.55 8.84 6.41 37.98
Peers
Company Name CMP
Sun Pharma. Inds. 1769.10
Dr. Reddys Labs. 1239.65
Cipla 1330.00
Lupin 1960.00
Zydus Lifesciences 1131.00
View more..